chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I noticed a strong ringing in both ears. The tinnitus is strong and has never went away. It is continuous and never stops. I have not went to the doctor. Nothing helps with the ringing and I know there is no cure for tinnitus. Then on my left eye, I developed a cranial bells palsy on 4/27/2022. This affected my vision. I am not for sure if the cranial bells palsy is due to the vaccine or not. At the moment, I am seeing a specialist and he is not for sure about the cause as well. I still have cranial bells palsy to this day. My doctor did say that it could take 2-6 months to go away. I am getting more tests and lab work done.
Parent said, 1 hr p/shot started throwing up, t103, screamed all noc, still screaming; In & out of consciousness; acts freaky; scream w/eyes open; doesn't know us; sees monsters;
Redness, pain and swelling at injection site. Headache, nausea diarrhea and fatigue.
Pt's "windpipe" swelled, 2 days post vax. He went to ER and received Benadryl and epinephrine. Pt had dizziness and pulse OX was 85%. Repeat pulse OX was 92% on room air. Swelling reoccurred the next morning. Pt administered more epinephrine.
Rose started with a swollen arm at vaccine site. Followed my fever, nausea, chills, aches.
Metallic taste in mouth; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: GR8737), via an unspecified route of administration in the left arm on 31Mar2021 at 17:30 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205), via an unspecified route of administration in the left arm on 03Mar2021 at 17:15 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Relevant medical history included diabetes. The patient had no known allergies to medications, food or other products. The patient received unspecified concomitant medication for unknown indication on an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On an unspecified date in 2021, the patient experienced metallic taste in mouth. The adverse event did not result in a doctor or other healthcare professional office/ clinic visit/ emergency room/ department or urgent care. The patient did not receive any treatment for the event experienced. The clinical outcome of the event metallic taste in mouth was not resolved at the time of report.  No follow-up attempts are needed. No further information is expected.
Patient felt dizzy standing up and had brief syncope. She did not lose consciousness. Mother caught her in her arms and no injuries occurred. She looked pale and needed about 10-15 minutes before getting up and dizziness subsided.  Pulse oximetry, BP, HR checked with no significant findings. Patient was advised to wait 30 minutes for observation, instructed to hydrate, inform guardian of any worsening symptoms and follow up with HCP.
per pt he was diagnosed COVID positive 3 wks prior to coming to the hospital; saw PCP and was sent to ED for dyspnea and cough not improving ;diagnosed with acute on chronic hypoxic respiratory failure due to pneumonia;  hx of COPD; required BiPAP; DNR/DNI; pt's condition worsened and he died in the hospital
I developed "Covid-Arm" after vaccine #2 and #3- a painful raised, red, warm area underneath my vaccination site. It stayed this way for several days after vaccination.  I had palpitations, and a resting heart rate in the 90's for 24 hours after vaccine #3.  My normal resting heart rate is in the low 70's per my Watch.  I also have an IUD and do not normally menstruate. My first cycle after the vaccine #3 lasted for 2 weeks.
Seconds after receiving vaccine my finger tips began to tingle and then body became hot, flushed, and heart palpitations with elevated BP. My head was pounding with heart beat. I began to see ?stars? and feeling lightheaded. Lasted 30min. They had me lay down and bend my knees. Then felt nausea. Drank water. After leaving I had intense shaking that eventually went away after about 30min.
Patient reported extreme exhaustion/fatigue for 3 days following injection Reported swollen lymph nodes for approximately 2 weeks after injection
Shot given approx 2" below shoulder on left arm, area red & bruised with pink area about 3" diameter surrounding site. Then area below site to elbow had rxn with redness, swelling, skin firm and mottled, very painful, low grade fever. Given TYLENOL & BENADRYL - parent has pictures of the reaction.
"Patient passed out after Pfizer shot first dose. Wheel chaired down to EMS area and agained passed out. Came to vitalized. given two chocolate chip cookies and water all appeared okay. Released after last set of vitalized:  (from EMT report)
fever/high temperature; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever/high temperature) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Aug-2021, the patient experienced PYREXIA (fever/high temperature). At the time of the report, PYREXIA (fever/high temperature) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: high (High) Body temperature: High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided. Treatment medications were not provided.
?Vaccine arm? or ?Covid arm?  itchy red swollen area at injection site, about 2? diameter and looks like one big hive.  Appeared on day 8 after vaccine. Still red, swollen and itchy 10 hours later.
This spontaneous report was received from a certified medical assistant (C.M.A.) and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not specified. On 18-DEC-2015, the patient was vaccinated with an improperly stored dose of M-M-R II (lot # L012479, expiry date 10-APR-2017, dose and route of administration were not provided). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Janssen COVID-19 Vaccine EUA. This is a report for Patient. Subject was an otherwise healthy and physically active individual with no notable medical history prior to receiving the Janssen Covid-19 vaccine. He received his first dose of the vaccine (Lot # 1855194) at the pharmacy on 11/11/2021. Several days after receiving the vaccine, Subject experienced pain in his right leg joints and had to leave work. He was seen at Urgent Care on 12/27/2021. Subject was prescribed Naproxen (NAPROSYN). Subject received a second dose of the Janssen COVID-19 vaccine (Lot # 211D217) at the pharmacy on 01/29/22. Subject traveled outside of the country and while away, he experienced increased pain on his right leg joints and had to return home. The pain eventually spread to his left leg joints and then to other parts of the body. Subject visited his primary care physician at local Medical facility several times. Subject's joints became swollen and he experienced difficulties walking. He went to the Emergency Room on 6/25/2022. He was prescribed oxyCODONE-acetaminophen (PERCOCET) and released. Subject's condition severely deteriorated. He experienced severe pain on multiple joints and could barely walk at that point. He was transported by ambulance to local Hospital on 7/12/2022. He remained hospitalized at Hospital until 07/27/2022 when he was released to Rehab. While at County Hospital, several tests were conducted on the subject. He was diagnosed with Inflammatory Polyarthritis and was prescribed several medications which included: cyclobenzaprine (FLEXERIL) famotidine (PEPCID) ferrous sulfate (IRON) oxyCODONE-acetaminophen (PERCOCET) polyethylene glycol (MIRALAX) predniSONE (DELTASONE) rifAMPIN (RIFADIN) Senna (SENOKOT) Subject stayed at Rehab after his release from County Hospital on 07/27/2022 for rehabilitation until 08/20/2022. While at Rehab, he was followed by a physical, Dr. He is now staying in his apartment. He is regularly visited by nurses, and currently follows several drug regimens. He is still experiencing pain on several joints with intermittent joint swelling. He is followed by his primary care physician, Dr. at local Medical Associates, and a Rheumatologist physician, Dr. of the Rheumatology and Arthritis Care Center.
pain; pain was causing blood pressure to be elevated/blood pressure elevation; Headache; injection pain/injection site extreme pain; pain was so bad could not sleep at night/sometimes he is not going to sleep until 02:00 the next mor; This is a spontaneous report received from a contactable consumer (patient's spouse) via a Pfizer-sponsored program. A 52-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in the left arm, on 23Apr2021 (lot number: EN0170), as 2nd dose, single dose, at age 52 years old, for COVID-19 immunisation, at a pharmacy/drug store. Medical history and concomitant medications were not reported. Historical vaccine included the first dose BNT162B2 (PFIZER BIONTECH COVID-19 VACCINE), administered in the left arm, on 24Mar2021 (lot number: EP6955), at age 52 years old, for COVID-19 immunisation. The patient did not have prior vaccinations within four weeks of BNT162B2. On 23Apr2021, the patient received his second dose of BNT162B2. On 23Apr2021 at 19:30, the patient experienced injection pain/injection site extreme pain. The patient did not act on it because he knew the injection site may be sore for a week. On 24Apr2021, the injection site was hurting bad but again he did not act on it because he knew it may sore but it had been a whole month and it was concerning. The reporter stated that the pain was causing the patient's blood pressure to be elevated. The reporter noticed the blood pressure elevation about 2 weeks after the second injection in the morning time (May2021). The patient also experienced headache at the same time as when the patient's blood pressure was elevated around the morning time, about 2 weeks after the second injection (May2021). It was reported that the pain was so bad that the patient could not sleep at night within a week of the second injection (Apr2021), time of onset was reported as "around 15:00 or 16:00 and as it goes over to the night 190:0 or 20:00, sometimes he is not going to sleep until 02:00 the next morning"). The events required physician's office visit on an unspecified date (reported as "the other day") and the reporter brought the events to the doctor's attention and stated that the patient was in pain throughout the day. The reporter was thinking of taking the patient to urgent care. Treatment for the event "injection pain/injection site extreme pain" and "pain" included heating pads, ice packs, lidocaine patches, unspecified cream and rubbing lotion to try and ease the pain. The reporter was thinking about Advil and asked every how many hours should the patient take the Advil. The outcome of the events was not recovered.  Follow-up attempts are needed. Further information is expected.
On 9/3/21:  50 yo Female reported to the EC c/o of allergic rxn.  Patient reported increased redness/swelling to upper left extremity after receiving COVID-19 vaccine on the previous Wednesday.  Also, notes lightheadedness with left wrist pain.  She had gone to Urgent Care & given antibiotic ointment but states that it progressively worsened over time & it has double in size.
190 patients (9 different lot numbers) received a vaccine past the beyond used by date; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date).    This case contains information for the 21st of 190 adult patients described by the reporter.  Concomitant Medication use information was not provided by reporter.  It was unknown if patient receive any other vaccines in the 4 weeks prior to COVID-19 vaccine.  Treatment Medication use information was not provided by reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-704335 (Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-704335:Master case
pt recv vax 16FEB96 & to ER p/discovered by mom or grandma to be cold & not breathing;DOA by ER MD 18FEB96;
Started bleeding as if my period is trying to start. I?ve been on birth control to help ovarian cysts since 13 and I have never had an early period or spotting. Heard this was something others experienced and wanted to add my data as well to help the Covid research.
Patient had shot at 11:25am by 3:30pm eyes stung a lot. By 6:00pm tongue (underneath) was swollen. Patient took a Benadryl. At night was achy and felt nauseous. The next AM throat was a bit sore then it felt swollen. Patient took Benadryl. Had flu symptoms until 4:30pm when they felt better. Also had chills maybe a fever but temp wasn't taken.
Within 20 minutes of receiving the vaccine, experienced tingling on both sides of mouth and sensation of numbness  in lower lip. Symptoms lasted for 15 minutes or so and resolved. No other symptoms noted.
Pt. complained of feeling tired with sore arm at injection site on the evening that the vaccine was given. By the next day she developed headache, low grade temperature, anterior cervical lymphadenopathy, pain behind her eyes and the vaccine area was erythematous and warm. Also noticed on either the second or third day that she developed another concentric area of erythema and tenderness in her mid-left arm, below the injection site. She felt much improved by the evening of the third day post vaccination.
Fever that started at 99.8 and by 8:00 a.m.was 110.  Took Tylenol and fever broke at about 2:00 p.m.
the patient experienced severe migraine and it is lasting for few days days.   she has a history of migraine, but according to the patient it is not as bad as what she is currently going through.
swelling; hardness; This spontaneous case was reported by an other health care professional and describes the occurrence of SWELLING (swelling) and INDURATION (hardness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for an unreported indication: RESTYLANE.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SWELLING (swelling) and INDURATION (hardness). At the time of the report, SWELLING (swelling) and INDURATION (hardness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided. Concomitant medication was not reported.
Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Mild, Systemic: Nausea-Mild
Initial case was received from a non-healthcare professional on 04 November 2013. An 89 years old female had received an intramuscular dose of FLUZONE HD vaccine, batch number U47982AA on 03 November 2013. Patient had no illness at the time of vaccination. Patient's physician diagnosed allergies, birth defects and medical conditions were unknown. On 03 November 2013 within a few hours of vaccination, the patient had vomiting, dizziness, fever/chills/shaking and aching. It was reported that the patient was recovering at the time of this report but was sleeping lot. Corrective treatments and laboratory investigations were not reported. As of this report, the patient had not recovered from the events. List of documents held by sender none.
This case was reported via medical records forwarded by a lawyer and described the occurrence of arthritis in a male subject in his forties who was vaccinated with LYMERIX (GlaxoSmithKline). The reporting lawyer did not specify the adverse events experienced by the subject. The following information was received on 08 April 2009 via medical records. The subject reported that he was vaccinated with LYMERIX in 2001. In November 2001, the subject was evaluated for neck pain, right arm numbness, and low back pain, and magnetic resonance imaging showed mild degenerative disc disease. On 30 January 2002, he was complained of chronic neck and back pain. On 14 May 2003, he was evaluated for polyarthralgias, intermittent numbness of the hands and toes, as well as diabetes, hypertension, reflux and hyperlipidemia. The subject reported that he had been evaluated by a neurologist and diagnosed with mild diabetic neuropathy and numbness related to a remote injury. Magnetic resonance imaging of the brain was unremarkable and of the neck was significant for stenosis and possible disc protrusion. The subject believed that he had Lyme arthritis, and noted that he had received LYMERIX in 2001. Assessment included polyarthralgias of unclear etiology. Upon follow up on 04 January 2005, the subject continued to be followed by pain management for neck and lower back pain. Treatment included ULTRACET. Assessment on 18 July 2005 included cervical spine pain and spurring, left shoulder pain, headache, and bilateral arm numbness. He was receiving ULTRAM "six per day" for increasing pain due to the bone spur in his neck". Between 03 January 2002 and 05 September 2007, the subject was followed regularly for shoulder joint pain, neck pain, cervical spondylosis with disc spur complex at C5/6, low back pain, buttock pain, neck pain, numbness and tingling of the fingers. Diagnoses included herniated nucleus pulposus (cervical), axial pain, lumbar degenerative disc disease, lumbar radiculopathy, right side sciatica, degenerative disc disease, cervical degenerative disc disease, and cervicalgia. Treatment included medications (KETOPROFEN, VIOXX, BACLOFEN, LIDOCAINE cream, MOBIC, TRAMADOL, FLEXERIL, NEURONTIN, VICOPROFEN, ZYDONE, TYLENOL, ULTRAM) and facet joint injections/ cervical epidural block. He was seen on 15 May 2008 with a flare of low back and coccyx pain, and assessment included lumbar degenerative disc disease, lumbar radiculopathy (resolved), cervical degenerative disc disease, and cervicalgia. Treatment included TRAMADOL, FLEXERIL, NEURONTIN, MOBIC, and VICOPROFEN, and he received a lumbar neuroforaminal injection. Neck pain persisted as recently as January 2009. On 10 February 2009, he presented with a three week history of severe left calf pain after going hunting, and assessment included myalgias of the left calf "suspect torn muscle". Treatment included LORTAB. This case was assessed as medically serious by GSK. At the time of reporting the outcome of the events was unspecified.
Each time I was extremely itchy on my scalp and in all joint areas.itching last for several hours.; Each time I was extremely itchy on my scalp and in all joint areas.itching last for several hours.; peri-orbital redness; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 55-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 04May2022 at 18:00 as dose 4 (booster), single (Lot number: FJ4989) at the age of 54 years, in right arm for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: ESTROGEN. Past drug history included: Neomycin, reaction(s): "known allergies: Neomycin", notes: known allergies: Neomycin. Vaccination history included: BNT162b2 (Dose Number: 3, Batch/Lot No: FF2587, Location of injection: Arm Right, Vaccine Administration Time: 12:00 PM), administration date: 08Oct2021, when the patient was 53-year-old, for COVID-19 immunization, reaction(s): "Each time I was extremely itchy on my scalp and in all joint areas.itching last for several hours. Also had peri-orbital redness each time", "Each time I was extremely itchy on my scalp and in all joint areas.itching last for several hours. Also had peri-orbital redness each time", "peri-orbital redness"; Covid-19 vaccine (DOSE 1; MANUFACTURER UNKNOWN), for COVID-19 immunization, reaction(s): "Each time I was extremely itchy on my scalp and in all joint areas.itching last for several hours. Also had peri-orbital redness each time", "peri-orbital redness", "Each time I was extremely itchy on my scalp and in all joint areas.itching last for several hours. Also had peri-orbital redness each time"; Covid-19 vaccine (DOSE 2; MANUFACTURER UNKNOWN), for COVID-19 immunization, reaction(s): "Each time I was extremely itchy on my scalp and in all joint areas.itching last for several hours. Also had peri-orbital redness each time", "peri-orbital redness", "Each time I was extremely itchy on my scalp and in all joint areas.itching last for several hours. Also had peri-orbital redness each time". The following information was reported: PRURITUS (non-serious), PRURITUS (non-serious), outcome "recovered" and all described as "Each time I was extremely itchy on my scalp and in all joint areas.itching last for several hours."; ERYTHEMA (non-serious), outcome "recovered", described as "peri-orbital redness". Therapeutic measures were not taken as a result of pruritus, pruritus, erythema.  Additional information: Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient had been tested positive for COVID-19 reported unknown.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201325402 same reporter/patient/event, different vaccine dose;US-PFIZER INC-202201325409 same reporter/patient/event, different vaccine dose;